$10,000 raised

$100,000 Goal

$10,000 raised

$100,000 Goal

MEET MICHELLE

Michelle was in her mid forties, living a full and vibrant life with her husband Michael and their two children, 14-year-old Eva and 16-year-old Max. She worked long hours, trained hard and knew her body well.

In July 2022, a fall on a family ski trip in Queenstown led to hernia surgery. It went smoothly, and she went back for what should have been a routine follow-up.

"I told my team I'd be back in 20 minutes. I never went back."

That appointment ended in a diagnosis of late-stage ovarian cancer. Michelle went through multiple surgeries and every treatment available to her, until her doctors told her there was nothing left to try. Her cancer was terminal.

A clinical trial became her only path forward. Today, Michelle is on that trial, and she is still here.

Clinical trials are what women reach for when the road runs out, and ANZGOG | WomenCan builds those trials for women across Australia and New Zealand. Michelle wants every woman who reaches the end of the road to find what she found. Another option.

Donate

Too many women in Australia are dying from gynaecological cancers

Today, 19 women will be diagnosed with a gynaecological cancer

6 women lose their lives to a gynaecological cancer every day

90% of women who are diagnosed don't have access to molecular profiling which could change their outcome

You can fund the work to prevent it

DONATE

We won't stop until every woman has access to the best possible cancer treatments

At ANZGOG | WomenCan we’re committed to pushing cutting-edge gynaecological cancer research forward.

But breakthroughs can only save lives if every woman has access to them.

That is the potential of Molecular Profiling.

Molecular profiling works by extracting DNA strands from a tumour sample, creating a detailed understanding of a woman’s unique cancer.

This helps doctors propose more targeted treatments and care. More importantly, it can easily tell doctors if a woman qualifies for a clinical trial – where she could access the latest life-extending treatments.

This all means fewer harsh treatments and needless side effects and more lives saved.

But today, more than 90% of women with gynaecological cancers will miss out on comprehensive molecular profiling. That means they also miss out on the chance to access the best treatments currently available.

"We know molecular profiling and access to clinical trials can significantly extend and improve lives. We must accelerate this progress to ensure no woman is left behind."

Professor Clare Scott AM, MBBS PhD FRACP FAHMS GAICD,
Chair, Australia New Zealand Gynaecological Oncology Group (ANZGOG)

With limited government funding and high costs, so many Australian women are still missing out on the treatments which could save their lives.

You have the power to change that. By supporting the Collabor8Women end-of-year fundraiser, you'll fund the vital work needed to make early molecular profiling a standard of care in Australia.

Donate today

Your gift could change the outcomes for thousands of women

"People ask if I’m in remission and I never know how to answer. I'm not in active treatment for cancer, but I'm on regular monitoring which feels at times as if we are just waiting around for the day it comes back."

Kirsty

"I'm so grateful to be on this trial that has kept the cancer stable. I've been feeling great and have been living a relatively 'normal' life doing the things I enjoy with the people I love."

Alex

"I had this ticking time bomb in my pelvis, meanwhile, my children were still so young. I am determined to fight for more time with them."

Ali

Donate today

Donate to fund life-saving gynaecological cancer research

Your Details

Payment Details

$10,000

$10,000 raised

$100,000 Goal

$10,000 raised

$100,000 Goal

MEET MICHELLE

Too many women in Australia are dying from gynaecological cancers

Today, 19 women will be diagnosed with a gynaecological cancer

6 women lose their lives to a gynaecological cancer every day

90% of women who are diagnosed don't have access to molecular profiling which could change their outcome

You can fund the work to prevent it

We won't stop until every woman has access to the best possible cancer treatments

"We know molecular profiling and access to clinical trials can significantly extend and improve lives. We must accelerate this progress to ensure no woman is left behind."

Your gift could change the outcomes for thousands of women